Archives
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2018-07
-
Targeting β-catenin/BCL9: Sensitizing Tumors to Immunotherap
2026-04-30
Feng et al. demonstrate that pharmacological inhibition of the β-catenin/BCL9 interaction restores anti-tumor immunity and overcomes resistance to immune checkpoint blockades in solid tumors. Their peptide-based strategy modulates Treg and dendritic cell infiltration, offering a targeted approach for sensitizing resistant colon and breast cancers to immunotherapy.
-
Genistein: Applied Workflows for Cancer Chemoprevention Rese
2026-04-30
Genistein, a selective protein tyrosine kinase inhibitor, enables precision in cancer chemoprevention and mechanotransduction studies through its quantifiable effects on cell proliferation and cytoskeleton-dependent signaling. This guide details optimized workflows, protocol parameters, and troubleshooting strategies to maximize reproducibility and translational impact in experimental oncology.
-
5-Methyl-CTP: Redefining mRNA Stability for Translational Sc
2026-04-29
This article explores the mechanistic and strategic frontiers of 5-Methyl-CTP, a 5-methyl modified cytidine triphosphate, in mRNA synthesis. By connecting chemical innovation to translational impact—exemplified by mRNA vaccine breakthroughs against H5N1 in dairy cattle—it offers actionable guidance for researchers navigating the competitive landscape of mRNA drug development. The discussion integrates evidence from recent literature and leading application guides, differentiates APExBIO’s offering, and provides protocol recommendations for maximal translational success.
-
HyperPFU™ High-Fidelity DNA Polymerase: Technical Use Guide
2026-04-29
HyperPFU™ high-fidelity DNA polymerase enables robust, accurate PCR of long or GC-rich DNA fragments that often challenge standard Taq or lower-fidelity enzymes. It is recommended for workflows where blunt-end, high-fidelity amplification is essential, but should not be used in protocols requiring 3'-A overhangs or sticky ends.
-
Necrosulfonamide (SKU B7731): Reliable MLKL Inhibition in Ne
2026-04-28
This article provides practical, scenario-driven guidance for cell death pathway research using Necrosulfonamide (SKU B7731). Addressing common laboratory challenges in necroptosis assay reproducibility and MLKL inhibitor selection, we evaluate NSA's performance, specificity, and protocol compatibility. Researchers will find actionable insights, grounded in peer-reviewed data, to optimize experimental outcomes and select reliable reagents.
-
Angiotensin 1/2 (2-7) Peptide: Applied Research Workflows &
2026-04-28
Angiotensin 1/2 (2-7) stands out as a precise tool for dissecting blood pressure regulation and vasoconstriction mechanisms in both cardiovascular and emerging viral disease models. This guide delivers actionable protocols, advanced use-cases, and troubleshooting strategies to maximize reproducibility and scientific impact with APExBIO’s high-purity peptide.
-
Shared Substrate Specificity of Caspase Inhibitors Unveiled
2026-04-27
This study introduces a potent caspase-8 inhibitor based on the IL-18 tetrapeptide sequence, revealing unexpected overlap in substrate and inhibitor specificity among inflammatory and apoptotic caspases. Notably, VX-765—a selective caspase-1 inhibitor—also inhibits caspase-8, challenging assumptions of caspase selectivity and informing future inflammasome and apoptosis research.
-
Oteseconazole (VT-1161): Optimizing Antifungal Workflows
2026-04-27
Oteseconazole (VT-1161) redefines antifungal research with its robust, selective inhibition of fungal CYP51, offering high potency even against fluconazole-resistant Candida. This article delivers actionable guidance on experimental workflows, troubleshooting, and comparative advantages, enabling researchers to maximize the impact of this next-generation antifungal agent in both routine and advanced assays.
-
Brefeldin A: Optimizing ER Stress and Apoptosis Assays in Ca
2026-04-26
Brefeldin A (BFA) is a powerful ER stress inducer and protein trafficking inhibitor, enabling precise dissection of apoptosis mechanisms in cancer models. This article delivers a practical, evidence-backed guide to maximizing BFA performance in advanced experimental workflows, with actionable troubleshooting and optimization tips for reproducible results.
-
AO/PI Staining Solution: Precision Fluorescent Cell Viabilit
2026-04-25
AO/PI Staining Solution enables robust, interference-free live/dead cell discrimination by leveraging dual fluorescent DNA dyes. Its precision and adaptability make it the reagent of choice for high-fidelity cell viability and apoptosis studies, especially in research demanding reproducible, mechanistically insightful data.
-
Bovine Insulin in Cell Culture: Protocols, Workflows & Optim
2026-04-24
Bovine insulin is a precision tool for boosting cell proliferation and metabolic control in culture applications. This article translates recent advances and rigorous protocols into actionable strategies, ensuring reproducible, high-sensitivity results for demanding biomedical assays. Discover how APExBIO’s product quality and workflow alignment set a new standard for experimental robustness.
-
(-)-JQ1: The Inactive Stereoisomer Elevating BET Inhibitor R
2026-04-24
(-)-JQ1, the inactive JQ1 stereoisomer, is the gold-standard control for dissecting BET bromodomain function in cancer epigenetics research. Learn how precise workflows and troubleshooting can maximize data fidelity and interpretability in BRD4-targeted assays.
-
Vacuolin-1: Precision Lysosomal Exocytosis Inhibitor Workflo
2026-04-23
Vacuolin-1 empowers cell biologists to dissect Ca2+-dependent lysosomal exocytosis with unmatched selectivity, enabling robust studies of membrane repair, trafficking, and signaling. This article delivers actionable protocols, troubleshooting, and workflow enhancements to maximize Vacuolin-1’s impact in experimental models, with direct translation from breakthrough cartilage pathology research.
-
Perineuronal Net Degradation Drives Social Memory Loss in AD
2026-04-23
This study reveals that degradation of perineuronal nets (PNNs) in the hippocampal CA2 region underlies social memory deficits in Alzheimer’s disease (AD) models. By identifying matrix metalloproteinases (MMPs) as key mediators of PNN loss and demonstrating that MMP inhibition preserves social cognition, the work highlights the extracellular matrix as a promising therapeutic target in AD.
-
Filipin III: Gold-Standard Cholesterol Detection Reagent
2026-04-22
Filipin III, a polyene macrolide antibiotic, is widely recognized for its specificity in detecting cholesterol within biological membranes. It enables ultrastructural visualization and quantification of cholesterol-rich microdomains, supporting advanced research in cell biology and membrane biochemistry.